Publication Information

{'id': 'https://openalex.org/W2414424409', 'doi': None, 'title': '[Clinical applications of recombinant complement inhibitors].', 'display_name': '[Clinical applications of recombinant complement inhibitors].', 'publication_year': 2004, 'publication_date': '2004-06-01', 'ids': {'openalex': 'https://openalex.org/W2414424409', 'mag': '2414424409', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/15510900'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15510900', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5027878407', 'display_name': 'Daniel Lipiński', 'orcid': 'https://orcid.org/0000-0002-0199-9245'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Daniel Lipiński', 'raw_affiliation_strings': ['Instytut Genetyki Człowieka PAN, Poznań. [email protected]'], 'affiliations': [{'raw_affiliation_string': 'Instytut Genetyki Człowieka PAN, Poznań. [email protected]', 'institution_ids': []}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026892702', 'display_name': 'Andrzej Pławski', 'orcid': 'https://orcid.org/0000-0002-0534-8941'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Andrzej Pławski', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5044846528', 'display_name': 'Wojciech Juzwa', 'orcid': 'https://orcid.org/0000-0002-9477-8563'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Wojciech Juzwa', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5028579980', 'display_name': 'Joanna Zeyland', 'orcid': 'https://orcid.org/0000-0002-1208-3291'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Joanna Zeyland', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5039540008', 'display_name': 'Ryszard Słomski', 'orcid': 'https://orcid.org/0000-0001-5601-7002'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Ryszard Słomski', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 0, 'institutions_distinct_count': 0, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.0, 'has_fulltext': False, 'cited_by_count': 0, 'citation_normalized_percentile': {'value': 0.0, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 0, 'max': 61}, 'biblio': {'volume': '16', 'issue': '96', 'first_page': '571', 'last_page': '5'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T13365', 'display_name': 'Medical and Biological Ozone Research', 'score': 0.8703, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T13365', 'display_name': 'Medical and Biological Ozone Research', 'score': 0.8703, 'subfield': {'id': 'https://openalex.org/subfields/2736', 'display_name': 'Pharmacology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T10993', 'display_name': 'Complement system in diseases', 'score': 0.8522, 'subfield': {'id': 'https://openalex.org/subfields/2403', 'display_name': 'Immunology'}, 'field': {'id': 'https://openalex.org/fields/24', 'display_name': 'Immunology and Microbiology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/anaphylatoxin', 'display_name': 'Anaphylatoxin', 'score': 0.9471127}, {'id': 'https://openalex.org/keywords/c4a', 'display_name': 'C4A', 'score': 0.6996784}, {'id': 'https://openalex.org/keywords/complement-control-protein', 'display_name': 'Complement control protein', 'score': 0.51081395}, {'id': 'https://openalex.org/keywords/complement', 'display_name': 'Complement', 'score': 0.5037016}, {'id': 'https://openalex.org/keywords/decay-accelerating-factor', 'display_name': 'Decay-accelerating factor', 'score': 0.4479409}], 'concepts': [{'id': 'https://openalex.org/C90582226', 'wikidata': 'https://www.wikidata.org/wiki/Q424292', 'display_name': 'Anaphylatoxin', 'level': 4, 'score': 0.9471127}, {'id': 'https://openalex.org/C111684460', 'wikidata': 'https://www.wikidata.org/wiki/Q334848', 'display_name': 'Complement system', 'level': 3, 'score': 0.86100566}, {'id': 'https://openalex.org/C79196540', 'wikidata': 'https://www.wikidata.org/wiki/Q14905298', 'display_name': 'Complement membrane attack complex', 'level': 4, 'score': 0.7598493}, {'id': 'https://openalex.org/C90630246', 'wikidata': 'https://www.wikidata.org/wiki/Q17854107', 'display_name': 'C4A', 'level': 3, 'score': 0.6996784}, {'id': 'https://openalex.org/C40767141', 'wikidata': 'https://www.wikidata.org/wiki/Q285697', 'display_name': 'Recombinant DNA', 'level': 3, 'score': 0.6077887}, {'id': 'https://openalex.org/C171279029', 'wikidata': 'https://www.wikidata.org/wiki/Q5128320', 'display_name': 'Classical complement pathway', 'level': 4, 'score': 0.558513}, {'id': 'https://openalex.org/C136449434', 'wikidata': 'https://www.wikidata.org/wiki/Q428253', 'display_name': 'Innate immune system', 'level': 3, 'score': 0.5329595}, {'id': 'https://openalex.org/C138873322', 'wikidata': 'https://www.wikidata.org/wiki/Q83130456', 'display_name': 'Complement control protein', 'level': 5, 'score': 0.51081395}, {'id': 'https://openalex.org/C112313634', 'wikidata': 'https://www.wikidata.org/wiki/Q7886648', 'display_name': 'Complement (music)', 'level': 5, 'score': 0.5037016}, {'id': 'https://openalex.org/C95444343', 'wikidata': 'https://www.wikidata.org/wiki/Q7141', 'display_name': 'Cell biology', 'level': 1, 'score': 0.46802455}, {'id': 'https://openalex.org/C8891405', 'wikidata': 'https://www.wikidata.org/wiki/Q1059', 'display_name': 'Immune system', 'level': 2, 'score': 0.46374923}, {'id': 'https://openalex.org/C189446657', 'wikidata': 'https://www.wikidata.org/wiki/Q4736500', 'display_name': 'Alternative complement pathway', 'level': 4, 'score': 0.46289554}, {'id': 'https://openalex.org/C8487232', 'wikidata': 'https://www.wikidata.org/wiki/Q5248822', 'display_name': 'Decay-accelerating factor', 'level': 4, 'score': 0.4479409}, {'id': 'https://openalex.org/C86803240', 'wikidata': 'https://www.wikidata.org/wiki/Q420', 'display_name': 'Biology', 'level': 0, 'score': 0.4451731}, {'id': 'https://openalex.org/C57409179', 'wikidata': 'https://www.wikidata.org/wiki/Q1218293', 'display_name': 'Lysis', 'level': 2, 'score': 0.41339296}, {'id': 'https://openalex.org/C185592680', 'wikidata': 'https://www.wikidata.org/wiki/Q2329', 'display_name': 'Chemistry', 'level': 0, 'score': 0.34570318}, {'id': 'https://openalex.org/C203014093', 'wikidata': 'https://www.wikidata.org/wiki/Q101929', 'display_name': 'Immunology', 'level': 1, 'score': 0.30470902}, {'id': 'https://openalex.org/C55493867', 'wikidata': 'https://www.wikidata.org/wiki/Q7094', 'display_name': 'Biochemistry', 'level': 1, 'score': 0.20781285}, {'id': 'https://openalex.org/C104317684', 'wikidata': 'https://www.wikidata.org/wiki/Q7187', 'display_name': 'Gene', 'level': 2, 'score': 0.15803382}, {'id': 'https://openalex.org/C127716648', 'wikidata': 'https://www.wikidata.org/wiki/Q104053', 'display_name': 'Phenotype', 'level': 3, 'score': 0.07374421}, {'id': 'https://openalex.org/C188082640', 'wikidata': 'https://www.wikidata.org/wiki/Q1780899', 'display_name': 'Complementation', 'level': 4, 'score': 0.0}], 'mesh': [{'descriptor_ui': 'D000706', 'descriptor_name': 'Anaphylatoxins', 'qualifier_ui': 'Q000096', 'qualifier_name': 'biosynthesis', 'is_major_topic': True}, {'descriptor_ui': 'D003169', 'descriptor_name': 'Complement Inactivator Proteins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D000706', 'descriptor_name': 'Anaphylatoxins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000818', 'descriptor_name': 'Animals', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015926', 'descriptor_name': 'Complement C3a', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015926', 'descriptor_name': 'Complement C3a', 'qualifier_ui': 'Q000096', 'qualifier_name': 'biosynthesis', 'is_major_topic': False}, {'descriptor_ui': 'D015934', 'descriptor_name': 'Complement C4a', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015934', 'descriptor_name': 'Complement C4a', 'qualifier_ui': 'Q000096', 'qualifier_name': 'biosynthesis', 'is_major_topic': False}, {'descriptor_ui': 'D015936', 'descriptor_name': 'Complement C5a', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015936', 'descriptor_name': 'Complement C5a', 'qualifier_ui': 'Q000096', 'qualifier_name': 'biosynthesis', 'is_major_topic': False}, {'descriptor_ui': 'D003169', 'descriptor_name': 'Complement Inactivator Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D011994', 'descriptor_name': 'Recombinant Proteins', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': False}], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/15510900', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'display_name': 'Reduced inequalities', 'score': 0.68, 'id': 'https://metadata.un.org/sdg/10'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3199352977', 'https://openalex.org/W3132760959', 'https://openalex.org/W2888961943', 'https://openalex.org/W2612959023', 'https://openalex.org/W2462315822', 'https://openalex.org/W2414424409', 'https://openalex.org/W2133876809', 'https://openalex.org/W2026695565', 'https://openalex.org/W2019974865', 'https://openalex.org/W2013771339'], 'abstract_inverted_index': {'The': [0, 29, 51, 97, 139], 'complement': [1, 52, 65, 95, 99, 119, 125], 'system': [2, 53, 143], 'constitutes': [3], 'an': [4, 102], 'important': [5], 'part': [6], 'of': [7, 18, 81, 94, 108, 114, 141, 147, 151], 'the': [8, 16, 25, 35, 63, 106, 112, 142, 148], 'innate': [9], 'immune': [10], 'system.': [11, 96], 'Complement': [12], 'activation': [13, 66, 100], 'leads': [14], 'to': [15, 69], 'generation': [17], 'C3a,': [19], 'C4a': [20], 'and': [21, 24, 47, 59, 62, 83, 87], 'C5a': [22], 'anaphylatoxins': [23, 30], 'membrane': [26], 'attack': [27, 40], 'complex.': [28], 'mediate': [31], 'multiple': [32], 'reactions': [33], 'in': [34, 105, 130], 'acute': [36], 'inflammatory': [37], 'response.': [38], 'Membrane': [39], 'complex': [41], 'inserts': [42], 'molecules': [43], 'into': [44], 'target': [45], 'membranes': [46], 'causes': [48], 'cell': [49, 71], 'lysis.': [50], 'can': [54, 121, 127], 'not': [55], 'discriminate': [56], 'between': [57], 'self': [58], 'non-self': [60], 'cells': [61], 'inappropriate': [64, 98], 'may': [67], 'lead': [68], 'host': [70], 'damage.': [72], 'This': [73], 'destructive': [74], 'activity': [75], 'is': [76], 'tightly': [77], 'regulated': [78], 'by': [79, 133], 'family': [80], 'structurally': [82], 'functionally': [84], 'related': [85], 'soluble': [86], 'membrane-bound': [88], 'proteins,': [89], 'which': [90], 'act': [91], 'as': [92], 'inhibitors': [93, 120, 126], 'plays': [101], 'essential': [103], 'role': [104], 'pathogenesis': [107], 'many': [109], 'diseases.': [110], 'In': [111], 'therapy': [113], 'these': [115], 'diseases': [116], 'specific': [117], 'recombinant': [118], 'be': [122, 128], 'used.': [123], 'Recombinant': [124], 'produced': [129], 'large': [131], 'amounts': [132], 'different': [134], 'eukaryotic': [135], 'or': [136], 'prokaryotic': [137], 'systems.': [138], 'choice': [140], 'depends': [144], 'on': [145], 'kind': [146], 'post-translational': [149], 'modifications': [150], 'proteins.': [152]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W2414424409', 'counts_by_year': [], 'updated_date': '2024-12-07T21:43:24.316309', 'created_date': '2016-06-24'}